title: Non-viral gene-activated matrices: next generation constructs for bone repair.
abstract: In the context of producing enhanced therapeutics for regenerative medicine, our laboratory develops gene-activated matrices (GAMs) using non-viral gene therapy (GT) in combination with collagen-based scaffolds engineered specifically for tissue repair. Non-viral vectors have been referred to as a minority pursuit in GT but considering the concerns associated with viral vectors and as transient gene expression is such a key consideration, further research is clearly warranted for tissue engineering (TE) applications. Mesenchymal stem cells (MSCs) are well regarded for their capability in bone regeneration but as primary cells, they are difficult to transfect. We have recently optimised the non-viral vector, polyethyleneimine (PEI), to achieve high transfection efficiencies in MSCs. Subsequently, a series of PEI-based GAMs were developed using collagen, collagen-glycosaminoglycan and collagen-nanohydroxyapatite (collagen-nHa) scaffolds whereby transgene expression was detected up to 21 d with the collagen-nHa scaffold providing the most prolonged expression. Moreover, all PEI-based GAMs contained a low plasmid DNA dose of 2 µg which is far below doses often required in previous GAMs. Having successfully developed these GAMs, the ephrinB2 gene has recently been incorporated to produce a novel therapeutic GAM for bone repair. Herein, we discuss our recent investigations in the development and application of non-viral GAMs.
authors.affiliation: Tissue Engineering Research Group, Department of Anatomy, Royal College of Surgeons in Ireland, Dublin, Ireland.
authors.forename: Erica G
authors.initials: EG
authors.lastname: Tierney
authors.forename: Garry P
authors.initials: GP
authors.lastname: Duffy
authors.forename: Sally-Ann
authors.initials: SA
authors.lastname: Cryan
authors.forename: Caroline M
authors.initials: CM
authors.lastname: Curtin
authors.forename: Fergal J
authors.initials: FJ
authors.lastname: O'Brien
mesh_terms: D000818:Animals; D001861:Bone Regeneration / Q000502:physiology*; D036388:Ephrin-B2 / Q000378:metabolism; D015870:Gene Expression; D005814:Genes, Viral / Q000235:genetics*; D015316:Genetic Therapy; D006801:Humans; D054457:Tissue Scaffolds / Q000737:chemistry*; D014162:Transfection; D014780:Viruses / Q000235:genetics*
chemical_list: D036388:Ephrin-B2
keywords: bone repair; gene-activated matrices; mesenchymal stem cells; non-viral gene delivery vectors; orthopaedic gene therapy; regenerative medicine; scaffolds; tissue engineering
references.citation: Science. 1999 Dec 17;286(5448):2244-5
references.pmid: 10636774
references.citation: Adv Mater. 2012 Feb 7;24(6):749-54
references.pmid: 22213347
references.citation: Lancet. 2011 Apr 2;377(9772):1175-82
references.pmid: 21388673
references.citation: Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):731-40
references.pmid: 20156499
references.citation: Nanomedicine. 2012 Apr;8(3):337-45
references.pmid: 21756861
references.citation: Biomaterials. 2006 Mar;27(7):1095-103
references.pmid: 16143394
references.citation: J Biol Chem. 2000 Mar 31;275(13):9645-52
references.pmid: 10734116
references.citation: Biomaterials. 2012 Jun;33(17):4319-26
references.pmid: 22440048
references.citation: Exp Cell Res. 1990 Oct;190(2):170-4
references.pmid: 2209719
references.citation: J Mater Sci Mater Med. 2010 Aug;21(8):2293-8
references.pmid: 20091099
references.citation: J Biomed Mater Res B Appl Biomater. 2006 Nov;79(2):263-7
references.pmid: 16649169
references.citation: J Biomed Mater Res B Appl Biomater. 2009 Aug;90(2):584-91
references.pmid: 19180526
references.citation: Tissue Eng. 2006 Mar;12(3):489-97
references.pmid: 16579682
references.citation: Plast Reconstr Surg. 2011 Jan;127 Suppl 1:60S-70S
references.pmid: 21200274
references.citation: Nat Biotechnol. 2011 Feb;29(2):121-8
references.pmid: 21301435
references.citation: J Biomed Mater Res A. 2003 Dec 15;67(4):1384-92
references.pmid: 14624526
references.citation: Cell Metab. 2006 Aug;4(2):111-21
references.pmid: 16890539
references.citation: Tissue Eng Part A. 2011 Jun;17(11-12):1643-50
references.pmid: 21306292
references.citation: Expert Rev Mol Med. 2010 Jun 23;12:e18
references.pmid: 20569532
references.citation: Trends Biotechnol. 2006 Jan;24(1):4-8
references.pmid: 16289395
references.citation: Oral Maxillofac Surg. 2011 Mar;15(1):31-9
references.pmid: 20644972
references.citation: Curr Opin Cell Biol. 2004 Oct;16(5):580-9
references.pmid: 15363810
references.citation: Biomaterials. 2004 Mar;25(6):1077-86
references.pmid: 14615173
references.citation: J Biomed Mater Res A. 2010 Aug;94(2):344-54
references.pmid: 20186740
references.citation: Biomaterials. 2010 Dec;31(35):9232-43
references.pmid: 20863559
references.citation: J Bone Miner Res. 2008 Aug;23(8):1170-81
references.pmid: 18627264
references.citation: Biomaterials. 2008 Jan;29(1):58-65
references.pmid: 17897711
references.citation: J Control Release. 2012 Mar 10;158(2):304-11
references.pmid: 22138069
references.citation: Br J Pharmacol. 2009 May;157(2):166-78
references.pmid: 19459843
references.citation: J Biomed Mater Res A. 2010 Dec 15;95(4):1142-9
references.pmid: 20878985
references.citation: Nat Mater. 2005 Jun;4(6):460-4
references.pmid: 15895097
references.citation: Oral Maxillofac Surg. 2012 Mar;16(1):47-55
references.pmid: 21968608
references.citation: Br J Pharmacol. 2009 May;157(2):153-65
references.pmid: 18776913
references.citation: Proc Natl Acad Sci U S A. 1989 Feb;86(3):933-7
references.pmid: 2915988
references.citation: J Nanosci Nanotechnol. 2010 May;10(5):3170-4
references.pmid: 20358915
references.citation: Curr Gene Ther. 2011 Feb;11(1):46-57
references.pmid: 21182464
references.citation: J Control Release. 2013 Feb 10;165(3):173-82
references.pmid: 23201622
references.citation: Tissue Eng Part B Rev. 2011 Dec;17(6):437-41
references.pmid: 21682607
references.citation: J Mech Behav Biomed Mater. 2009 Apr;2(2):202-9
references.pmid: 19627824
references.citation: Mol Ther. 2007 Sep;15(9):1655-62
references.pmid: 17551504
references.citation: Dev Cell. 2004 Oct;7(4):465-80
references.pmid: 15469835
references.citation: Hum Gene Ther. 2005 May;16(5):609-17
references.pmid: 15916485
references.citation: Science. 1999 Apr 2;284(5411):143-7
references.pmid: 10102814
references.citation: Arthritis Rheum. 2008 Feb;58(2):475-88
references.pmid: 18240212
references.citation: Lancet. 2008 Dec 13;372(9655):2023-30
references.pmid: 19022496
references.citation: Eur Cell Mater. 2010 Oct 04;20:218-30
references.pmid: 20922667
references.citation: Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):683-98
references.pmid: 20114067
references.citation: Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5753-8
references.pmid: 8650165
references.citation: J Biomed Mater Res A. 2013 May;101(5):1353-61
references.pmid: 23077084
references.citation: J Cell Mol Med. 2011 Sep;15(9):1989-98
references.pmid: 20629995
references.citation: J Bone Joint Surg Am. 2002 Jul;84(7):1123-31
references.pmid: 12107310
references.citation: Br J Pharmacol. 2009 May;157(2):151-2
references.pmid: 19459842
references.citation: Biomaterials. 2010 Apr;31(10):2893-902
references.pmid: 20044134
references.citation: Gene Ther. 2005 Aug;12(15):1171-9
references.pmid: 15815701
references.citation: J Cell Physiol. 2012 Feb;227(2):416-20
references.pmid: 21948071
references.citation: Nature. 2002 Nov 14;420(6912):116-8
references.pmid: 12432357
references.citation: Biomaterials. 2010 Jan;31(3):461-6
references.pmid: 19819008
references.citation: Front Biosci (Elite Ed). 2012 Jun 01;4:2647-53
references.pmid: 22652667
references.citation: Nat Med. 1999 Jul;5(7):753-9
references.pmid: 10395319
references.citation: Cell Tissue Res. 2010 Apr;340(1):169-77
references.pmid: 20198386
references.citation: Cell. 2008 Apr 4;133(1):38-52
references.pmid: 18394988
references.citation: Mol Ther. 2012 Oct;20(10):1831-2
references.pmid: 23023051
references.citation: Tissue Eng Part A. 2010 Sep;16(9):2755-68
references.pmid: 20491587
references.citation: Nature. 2009 Nov 26;462(7272):426-32
references.pmid: 19940912